Enliven Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $271.9M
Liabilities Breakdown FY2023
Total Liabilities: $26.0M
Asset Breakdown
Total Assets: $271.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $100.1M | 36.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $742.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $171.0M | 62.9% |
Liabilities Breakdown
Total Liabilities: $26.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $532.0K | 2.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $25.4M | 98.0% |